There are 142 resources available
57P - International Ovarian Tumor Analysis (IOTA) Simple Ultrasound Rules and Risk of Malignancy Index in differentiating benign from malignant ovarian masses
Presenter: Sakshi Modi
Session: Poster Display session
58P - The lymphocyte activation gene-3 (LAG-3) protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma
Presenter: Sumika Zaitsu
Session: Poster Display session
59P - Expression of CD47 a potent ‘don’t eat me’ signal’ in ovarian cancer (OC): Correlation with other immune features and evolution under neoadjuvant chemotherapy (NACT), a GINEGEPS study
Presenter: Laure Chardin
Session: Poster Display session
60P - Deciphering CD8+ T-cell-related gene signatures in the tumor microenvironment to predict the immunotherapy response and prognosis of ovarian cancer patients
Presenter: Yunshu Zhu
Session: Poster Display session
61P - Fluorescent detection of epithelial cells in intraoperative flushes in ovarian cancer in the "liquid biochip" format
Presenter: Irina Kruglova
Session: Poster Display session
62P - Development of deep learning-based auto-segmentation algorithms to diagnose and indicate peritoneal carcinomatosis lesions of ovarian cancer
Presenter: Se Ik Kim
Session: Poster Display session
63P - Redefining the role of CA 19-9 as a prognostic marker in Epithelial Ovarian Cancer
Presenter: Eshwarya kaur
Session: Poster Display session
64P - Malignant Brenner Tumor of the Ovary: impact of adjuvant chemotherapy, age, race, laterality and stage on survival outcome
Presenter: Asmaa Ellaithy
Session: Poster Display session
65P - Clinical outcomes in ovarian clear cell carcinoma: A UK single centre experience
Presenter: Shira Peleg Hasson
Session: Poster Display session
66P - PD-L1 expression following neoadjuvant chemotherapy is upregulated and serves as a prognostic factor in patients with advanced high-grade serous ovarian carcinoma
Presenter: Mitsutake Yano
Session: Poster Display session